Skip to content
10-K

Annual Report

TECHPRECISION CORP TPCS

0001410578-25-001537

← back to feed
Filed
Jul 30, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Jul 15, 2025 9.78M sh
Shares Diluted FY 2025 · Mar 31, 2025 9.46M sh
Shares Diluted FY 2025 · Mar 31, 2024 8.72M sh
Capex FY 2025 · Mar 31, 2025 $4.12M
Capex restated FY 2025 · Mar 31, 2024 $3.23M
Operating Cash Flow FY 2025 · Mar 31, 2025 −$599K
Operating Cash Flow restated FY 2025 · Mar 31, 2024 $728K
Long Term Debt FY 2025 · Mar 31, 2025 $3K
Cash And Equivalents FY 2025 · Mar 31, 2025 $195K
Cash And Equivalents restated FY 2025 · Mar 31, 2024 $138K
Stockholders Equity FY 2025 · Mar 31, 2025 $8.74M
Stockholders Equity restated FY 2025 · Mar 31, 2024 $7.8M
Stockholders Equity restated FY 2025 · Mar 31, 2023 $14.59M
Current Liabilities FY 2025 · Mar 31, 2025 $16.92M
Current Liabilities restated FY 2025 · Mar 31, 2024 $17.75M
Total Liabilities FY 2025 · Mar 31, 2025 $24.79M
Total Liabilities restated FY 2025 · Mar 31, 2024 $26.94M
Current Assets FY 2025 · Mar 31, 2025 $15.35M
Current Assets restated FY 2025 · Mar 31, 2024 $14.85M
Total Assets FY 2025 · Mar 31, 2025 $33.53M
Total Assets restated FY 2025 · Mar 31, 2024 $34.75M
Eps Diluted FY 2025 · Mar 31, 2025 −$0.29
Eps Diluted FY 2025 · Mar 31, 2024 −$0.81
Eps Basic FY 2025 · Mar 31, 2025 −$0.29
Eps Basic FY 2025 · Mar 31, 2024 −$0.81
Sga Expense FY 2025 · Mar 31, 2025 $6.49M
Sga Expense restated FY 2025 · Mar 31, 2024 $8.75M
Net Income FY 2025 · Mar 31, 2025 −$2.75M
Net Income restated FY 2025 · Mar 31, 2024 −$7.04M
Operating Income FY 2025 · Mar 31, 2025 −$2.16M
Operating Income restated FY 2025 · Mar 31, 2024 −$4.63M
Gross Profit FY 2025 · Mar 31, 2025 $4.33M
Gross Profit restated FY 2025 · Mar 31, 2024 $4.12M
Cost Of Revenue FY 2025 · Mar 31, 2025 $29.7M
Cost Of Revenue FY 2025 · Mar 31, 2024 $27.47M
Revenue FY 2025 · Mar 31, 2025 $34.03M
Revenue restated FY 2025 · Mar 31, 2024 $31.59M